Ranbaxy Laboratories Says Daiichi Pharmaceutical Co., Ltd. Deal on Track, Shares Rise

NEW DELHI, July 16 (Reuters) - Ranbaxy Laboratories Ltd's deal for a takeover by Japan's Daiichi Sankyo remains on track and the Indian firm will give U.S. authorities all information needed for a probe within the next month, it said on Wednesday.
MORE ON THIS TOPIC